Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease Response

被引：0
|
作者：
Sawada, H. [1 ]
Oeda, T. [1 ]
Yamamoto, K. [1 ]
机构：
[1] Natl Utano Hosp, Clin Res Ctr, Dept Neurol, Kyoto, Japan
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2010年 / 17卷 / 02期
关键词：
diabetes mellitus; MIBG; sympathetic nerve; Parkinson disease;
D O I：
10.1111/j.1468-1331.2009.02864.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E10 / E10
页数：1
相关论文
共 50 条
  • [21] Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease
    Mitsui, J
    Saito, Y
    Momose, T
    Shimizu, J
    Arai, N
    Shibahara, J
    Ugawa, Y
    Kanazawa, I
    Tsuji, S
    Murayama, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 243 (1-2) : 101 - 104
  • [22] Diagnostic accuracy in early Parkinson's disease
    Rajput, AH
    Jankovic, J
    McDermott, M
    NEUROLOGY, 1997, 48 (03) : 60001 - 60001
  • [23] Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy
    Matsui, H
    Udaka, F
    Oda, M
    Kubori, T
    Nishinaka, K
    Kameyama, M
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2005, 119 (01): : 56 - 60
  • [24] Levodopa challenge test and 123I-metaiodobenzylguanidine scintigraphy for diagnosing Parkinson's disease
    Asayama, S.
    Wate, R.
    Kaneko, S.
    Asayama, T.
    Oki, M.
    Tsuge, A.
    Nagashima, M.
    Morita, J.
    Nakamura, S.
    Nakamura, M.
    Nishii, M.
    Fujita, K.
    Saito, A.
    Nakano, S.
    Ito, H.
    Kusaka, H.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 128 (03): : 160 - 165
  • [25] Accuracy and cutoff values of delayed heart to mediastinum ratio with 123I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses
    Guillaume Lamotte
    Rémy Morello
    Adrien Lebasnier
    Denis Agostini
    Gilles L. Defer
    BMC Neurology, 15
  • [26] Diagnostic Accuracy of Apparent Diffusion Coefficient and 123I-Metaiodobenzylguanidine for Differentiation of Multiple System Atrophy and Parkinson's Disease
    Umemura, Atsushi
    Oeda, Tomoko
    Hayashi, Ryutaro
    Tomita, Satoshi
    Kohsaka, Masayuki
    Yamamoto, Kenji
    Sawada, Hideyuki
    PLOS ONE, 2013, 8 (04):
  • [27] Evaluation of Parkinson Disease and Alzheimer Disease with the Use of Neuromelanin MR Imaging and 123I-Metaiodobenzylguanidine Scintigraphy
    Miyoshi, F.
    Ogawa, T.
    Kitao, S. -i.
    Kitayama, M.
    Shinohara, Y.
    Takasugi, M.
    Fujii, S.
    Kaminou, T.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2013, 34 (11) : 2113 - 2118
  • [28] Cardiac sympathetic imaging with radiolabelled metaiodobenzylguanidine (MIBG) in patients with Parkinson's disease
    Takatsu, H
    Satomi, K
    Nishida, H
    Matsuo, H
    Watanabe, S
    Nagashima, K
    Fujiwara, H
    CATECHOLAMINE RESEARCH: FROM MOLECULAR INSIGHTS TO CLINICAL MEDICINE, 2002, 53 : 487 - 490
  • [29] Metaiodobenzylguanidine Myocardial Scintigraphy Identifies Premotor Parkinson's Disease During a Negative Dopamine Transporter Scan
    Tateno, Hiromi
    Sakakibara, Ryuji
    Tateno, Fuyuki
    Tuyusaki, Yohei
    Aiba, Yosuke
    Kishi, Masahiko
    Tateno, Akihiko
    Ogata, Tsuyoshi
    Doi, Hirokazu
    Inaoka, Tsutomu
    Terada, Hitoshi
    Suzuki, Yasuo
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 (11) : 2428 - 2430
  • [30] Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism
    Kim, Joong-Seok
    Lee, Phil-Hyu
    Lee, Kwang-Soo
    Park, Jeong-Wook
    Kim, Yeong-In
    Chung, Yong-An
    Kim, Sung-Hoon
    Kim, Seung-Hyun
    Kim, Juhan
    Choi, Yun-Young
    Kim, Hee-Tae
    MOVEMENT DISORDERS, 2006, 21 (11) : 1990 - 1994
12345